[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100595302":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":21,"centralContacts":25,"locations":34,"responsibleParty":88,"collaborators":10,"id":90,"slug":91,"hasResults":92,"nctId":93,"briefTitle":94,"officialTitle":94,"acronym":10,"eligibilityCriteria":95,"healthyVolunteers":96,"sex":97,"minAge":98,"maxAge":10,"enrollmentInfo":99,"targetDuration":10,"studyType":102,"phases":10,"briefSummary":103,"conditions":104,"keywords":110,"overallStatus":81,"whyStopped":10,"lastUpdateSubmitDate":115,"lastUpdatePostDateStruct":116,"startDateStruct":119,"completionDateStruct":121,"leadSponsor":123,"locationsCount":124},{"fullName":5,"class":6},"Memorial Sloan Kettering Cancer Center","OTHER",[8,11],{"label":9,"type":10,"description":10,"interventionNames":10},"Arm 1: Usual Care",null,{"label":12,"type":10,"description":10,"interventionNames":13},"Arm 2: Exercise",[14],"Behavioral: Exercise",[16],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":10},"BEHAVIORAL","Exercise","Exercise following completion of active treatment for the primary index cancer",[12],[22],{"name":23,"affiliation":5,"role":24},"Jessica Scott, PhD","PRINCIPAL_INVESTIGATOR",[26,30],{"name":23,"role":27,"phone":28,"phoneExt":10,"email":29},"CONTACT","646-888-8093","scottj1@mskcc.org",{"name":31,"role":27,"phone":32,"phoneExt":10,"email":33},"Chaya Moskowitz, PhD","646-227-3607","moskowc1@MSKCC.ORG",[35,53,66,79],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"City of Hope Cancer Center (Data Analysis Only)","NOT_YET_RECRUITING","Duarte","California","91010","United States","US",{"type":44,"coordinates":45},"Point",[46,47],-117.97729,34.13945,{"lat":47,"lon":46},[50],{"name":51,"role":27,"phone":52,"phoneExt":10,"email":10},"Lee Jones, PhD","646-677-7440",{"facility":54,"status":37,"city":55,"state":39,"zip":56,"country":41,"countryCode":42,"cosmosGeoPoint":57,"geoPoint":61,"contacts":62},"University of California, Los Angeles (Data or Specimen Analysis Only)","Los Angeles","90095-1781",{"type":44,"coordinates":58},[59,60],-118.24368,34.05223,{"lat":60,"lon":59},[63],{"name":64,"role":27,"phone":65,"phoneExt":10,"email":10},"Paul Boutros, PhD","310-794-7160",{"facility":67,"status":37,"city":68,"state":68,"zip":69,"country":41,"countryCode":42,"cosmosGeoPoint":70,"geoPoint":74,"contacts":75},"Weill Cornell Medical College (Data or Specimen Analysis Only)","New York","10021",{"type":44,"coordinates":71},[72,73],-74.00597,40.71427,{"lat":73,"lon":72},[76],{"name":77,"role":27,"phone":78,"phoneExt":10,"email":10},"Xiaoyue Ma","646-962-8029",{"facility":80,"status":81,"city":68,"state":68,"zip":82,"country":41,"countryCode":42,"cosmosGeoPoint":83,"geoPoint":85,"contacts":86},"Memorial Sloan Kettering Cancer Center (All Protocol Activities)","RECRUITING","10065",{"type":44,"coordinates":84},[72,73],{"lat":73,"lon":72},[87],{"name":23,"role":27,"phone":28,"phoneExt":10,"email":10},{"type":89,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100595302","association-between-exercise-patient-reported-outcomes-and-clinical-events-in-adult-cancer-survivors-100595302",false,"NCT07030686","Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors","Inclusion Criteria:\n\nTarget trial (ideal RCT)\n\n* Adult (≥18 years of age) patients with history of primary invasive cancer under surveillance at Memorial Sloan Kettering Cancer Center (MSK).\n* Completion of an exercise survey (baseline) as part of MSK Cancer Survivorship Program and completion of a historical survey in the MSK Cancer Survivorship Program 9-15 months (time th) prior reporting non-exercising status \\[i.e., reporting \\\u003C10 metabolic equivalent-hours per week (MET-h\u002Fweek)\\]. Patients completing an additional exercise survey between th and baseline are excluded.\n* No evidence of recurrent or metastatic disease in the 15 months prior to the baseline exercise assessment\n* Completion of all definitive primary adjuvant therapy (e.g., chemotherapy, radiotherapy, targeted therapy) at least 3 months prior to completion of the historical exercise survey in a MSK Cancer Survivorship Program. Adjuvant hormonal therapy is permitted at any time.\n* Undergoing surveillance in the Cancer Survivorship Program at MSK\n\nEmulation using observational data\n\n* Adult (≥18 years of age) cancer survivors under surveillance at Memorial Sloan Kettering Cancer Center (MSK) between 2011 and 2023.\n* Assessment of self-reported exercise status via completion of an exercise survey as part of MSK Cancer Survivorship Program standard intake (baseline assessment).\n* Non-exercising (i.e., reporting \\\u003C5 MET-h\u002Fweek) via completion of an exercise survey as part of MSK Cancer Survivorship Program standard intake 9-15 months prior to the baseline exercise assessment (historical exercise survey).\n* Documented history of the following absolute contraindications to moderate-intensity exercise at any time prior to the baseline exercise assessment, assessed using the Elixhauser ICD codes: Congestive heart failure, valvular disease, chronic pulmonary disease, or renal failure.\n* No evidence of recurrent or metastatic disease via radiological or pathological in EMR in the 15 months prior to the baseline exercise assessment.\n* Completion of all definitive primary adjuvant therapy (e.g., chemotherapy, radiotherapy, targeted therapy) at least 3 months prior to completion of historical exercise survey (i.e., at least 3 months prior to t-1) as part of MSK Cancer Survivorship Program standard intake. Adjuvant endocrine therapy is permitted.",true,"ALL","18 Years",{"count":100,"type":101},1000,"ESTIMATED","OBSERVATIONAL","This protocol is a retrospective study using observational data to conduct a target trial emulation to examine the association of exercise on cancer specific endpoints and other clinical outcomes in cancer survivors.",[105,106,107,108,109],"Survivorship","Recurrent","Recurrence","Cancer","Remission",[105,18,111,112,113,114,5],"cancer survivor","adult cancer survivor","no evidence of disease","20-101","2026-04-27",{"date":117,"type":118},"2026-04-28","ACTUAL",{"date":120,"type":118},"2020-03-19",{"date":122,"type":101},"2027-03-19",{"name":5,"class":6},4]